dysregulation < each < eadv

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 40.
[0-20] [0 - 20][0 - 40][20-40]

Ident.	Authors (with country if any)	Title
000016 (2009)	Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine]	The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
000066 (2013)	Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]	Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000085 (2011)	Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]	Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000088 (2011)	Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis]	Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
000101 (2012)	K. Krüger [Allemagne]	Medikamentöse Interaktionen in der Rheumatologie
000160 (2011)	Susumu Nishiyama [Japon] ; Tetsushi Aita [Japon] ; Yasuhiko Yoshinaga [Japon] ; Hiroki Kishimoto [Japon] ; Michio Toda [Japon] ; Yoshiki Yoshihara [Japon] ; Shinya Miyoshi [Japon] ; Akira Manki [Japon] ; Shoji Miyawaki [Japon]	Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis
000172 (2011)	Maneesh Gogia [États-Unis] ; Daniel E. Furst [États-Unis]	Rheumatoid arthritis and pregnancy: Disease activity, pregnancy outcomes, and treatment options during pregnancy and lactation
000189 (2013)	Diogo Mendes [Portugal] ; Carlos Alves [Portugal] ; Francisco Batel Marques [Portugal]	Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events
000206 (2012)	K. Krüger [Allemagne] ; J. Sieper [Allemagne]	Off-Label-Therapie bei rheumatoider Arthritis und Spondyloarthritiden
000228 (2012)	Tomoyuki Imagawa [Japon] ; Syuji Takei [Japon] ; Hiroaki Umebayashi [Japon] ; Kenichi Yamaguchi [Japon] ; Yasuhiko Itoh [Japon] ; Toshinao Kawai [Japon] ; Naomi Iwata [Japon] ; Takuji Murata [Japon] ; Ikuo Okafuji [Japon] ; Mari Miyoshi [Japon] ; Yasuhiro Onoe [Japon] ; Yoshifumi Kawano [Japon] ; Noriko Kinjo [Japon] ; Masaaki Mori [Japon] ; Neelufar Mozaffarian [États-Unis] ; Hartmut Kupper [Allemagne] ; Sourav Santra [Inde] ; Gina Patel [États-Unis] ; Shinichi Kawai [Japon] ; Shumpei Yokota [Japon]	Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
000280 (2010)	Valeria Bruno [Italie] ; Giuseppe Battaglia [Italie] ; Ferdinando Nicoletti [Italie]	The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases
000282 (2010)	Gert Hein [Allemagne] ; Thorsten Eidner [Allemagne] ; Peter Oelzner [Allemagne] ; Michael Rose [Allemagne] ; Alexander Wilke [Allemagne] ; Gunter Wolf [Allemagne] ; Sybille Franke [Allemagne]	Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study
000296 (2012)	Adel Alawadhi [Koweït] ; Khaldoon Alawneh [Jordanie] ; Zeyad Ahmed Alzahrani [Arabie saoudite]	The effect of neutralizing antibodies on the sustainable efficacy of biologic therapies: what’s in it for African and Middle Eastern rheumatologists
000300 (2012)	Joerg-Patrick Stübgen [États-Unis]	Targeted immunotherapy trials for idiopathic inflammatory myopathies
000748 (2012)	Ariel C. Bulua [États-Unis] ; Douglas B. Mogul [États-Unis] ; Ivona Aksentijevich [États-Unis] ; Harjot Singh [États-Unis] ; David Y. He [États-Unis] ; Larry R. Muenz [États-Unis] ; Michael M. Ward [États-Unis] ; Cheryl H. Yarboro [États-Unis] ; Daniel L. Kastner [États-Unis] ; Richard M. Siegel [États-Unis] ; Keith M. Hull [États-Unis]	Efficacy of etanercept in the tumor necrosis factor receptor–associated periodic syndrome: A prospective, open‐label, dose‐escalation study
000862 (2011)	Shunichi Shiozawa [Japon] ; Ken Tsumiyama [Japon] ; Kohsuke Yoshida [Japon] ; Akira Hashiramoto [Japon]	Pathogenesis of Joint Destruction in Rheumatoid Arthritis
000A42 (2012)	Meryem Can [Turquie] ; Fatma Alibaz-Öner [Turquie] ; Sibel Y Lmaz-Öner [Turquie] ; Pamir Atagündüz [Turquie] ; Nevsun Nanç [Turquie] ; Haner Direskeneli [Turquie]	Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience
000A50 (2011)	Jisna R. Paul [États-Unis] ; Prabha Ranganathan [États-Unis]	Clinical trials in rheumatoid arthritis: a status report from the ClinicalTrials.gov website
000B44 (2012)	W. Rigby [États-Unis] ; H. Tony [Allemagne] ; K. Oelke [États-Unis] ; B. Combe [France] ; A. Laster [États-Unis] ; C. A. Von Muhlen [Brésil] ; E. Fisheleva [Royaume-Uni] ; C. Martin [Royaume-Uni] ; H. Travers [Royaume-Uni] ; W. Dummer [États-Unis]	Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial
000C90 (2012)	Hiromoto Hisada [Japon] ; Hiroko Tsutsumi [Japon] ; Hiroki Ishida [Japon] ; Yoji Hata [Japon]	High production of llama variable heavy-chain antibody fragment (VHH) fused to various reader proteins by Aspergillus oryzae
000E17 (2013)	R. H. Osborne [Australie]	SP0132 Pro development to improve and deepen understanding of clinical outcomes

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "each" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "each" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    each
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021